Paul D'Angio

Title: Paul D'Angio: Innovator in Pharmaceutical Compositions

Introduction

Paul D'Angio is a notable inventor based in Basking Ridge, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 2 patents to his name, D'Angio's work has the potential to impact the treatment of various diseases.

Latest Patents

D'Angio's latest patents focus on pharmaceutical compositions and dosage forms of thalidomide. These patents disclose single unit dosage forms of thalidomide and pharmaceutically acceptable stereoisomers, prodrugs, salts, solvates, hydrates, or clathrates. The patents also outline methods for treating, managing, and preventing diseases such as leprosy, chronic graft-vs-host disease, rheumatoid arthritis, sarcoidosis, inflammatory bowel disease, and cancer using these novel dosage forms.

Career Highlights

D'Angio is currently associated with Celgene Corporation, where he continues to advance his research in pharmaceutical innovations. His work is characterized by a commitment to improving patient outcomes through effective medication delivery systems.

Collaborations

D'Angio collaborates with John A McCarty, contributing to the development of groundbreaking pharmaceutical solutions.

Conclusion

Paul D'Angio's contributions to pharmaceutical compositions and his innovative approach to dosage forms highlight his role as a key inventor in the field. His work promises to enhance treatment options for various medical conditions, showcasing the importance of innovation in healthcare.